Health TrialsbyHealthPanel

RISS Versus ESP Block in Laparoscopic Cholecystectomy

ConditionPostoperative Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorFerit Yetik

About this trial

This prospective randomized controlled trial aims to compare the analgesic efficacy and effects on diaphragmatic function of bilateral erector spinae plane (ESP) block and bilateral rhomboid intercostal-subserratus plane (RISS) block in patients undergoing elective laparoscopic cholecystectomy. Postoperative pain scores, opioid consumption, diaphragmatic excursion, pulmonary function, and recovery outcomes will be evaluated.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 75 years

ASA physical status I-III

Scheduled for elective laparoscopic cholecystectomy under general anesthesia

Provision of written informed consent

Disqualifiers

Coagulation disorders or anticoagulant therapy

Known allergy to local anesthetics

Infection at the block application site

Pregnancy or lactation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Erector Spinae Plane Block

    Procedure/Surgery

    Bilateral ultrasound-guided erector spinae plane block performed before laparoscopic cholecystectomy for postoperative analgesia.

  • Rhomboid Intercostal-Subserratus Plane Block

    Procedure/Surgery

    Bilateral ultrasound-guided rhomboid intercostal-subserratus plane block performed before laparoscopic cholecystectomy for postoperative analgesia.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: ESP BlockExperimental treatment 1 intervention
Group B: RISS BlockExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total Postoperative Tramadol Consumption

Total tramadol consumption during the first 24 hours after laparoscopic cholecystectomy.

Time frame
24 hours after surgery

Secondary outcomes

1

Postoperative Pain Scores

Postoperative pain scores assessed using the Numeric Rating Scale (NRS).

Time frame
0-24 hours after surgery
2

Time to First Rescue Analgesia

Time from the end of surgery to first rescue analgesic requirement.

Time frame
24 hours after surgery
3

Intraoperative Remifentanil Consumption

Total remifentanil consumption during surgery.

Time frame
During surgery
4

Opioid-Related Adverse Events

Incidence of nausea, vomiting, pruritus and other opioid-related adverse events.

Time frame
24 hours after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ferit Yetik

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Sponsor institution

Bursa City Hospital

Collaborator

Source ClinicalTrials.gov
Apply now